Antipsychotic Drugs Global Market Report 2025

Description

Antipsychotic drugs are medications primarily used to manage and treat symptoms of psychosis, including delusions, hallucinations, paranoia, and disordered thinking. Psychosis is often linked with psychiatric conditions such as schizophrenia, bipolar disorder, and severe depression. These medications are also known as neuroleptics or major tranquilizers.

Antipsychotic drugs are classified into first-generation, second-generation, and third-generation categories. First-generation drugs, the earliest developed, primarily work by blocking dopamine receptors in the brain, which helps alleviate hallucinations and delusions. They are prescribed for various conditions, including schizophrenia, bipolar disorder, unipolar depression, and dementia. These drugs are available through multiple distribution channels, such as hospital pharmacies, drug stores, and online pharmacies.

The antipsychotic drugs market research report is one of a series of new reports from The Business Research Company that provides antipsychotic drugs market statistics, including the antipsychotic drugs industry global market size, regional shares, competitors with the antipsychotic drugs market share, detailed antipsychotic drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the antipsychotic drugs industry. These antipsychotic drugs market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The antipsychotic drugs market size has grown rapidly in recent years. It will grow from $19.5 billion in 2024 to $21.45 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to the rising prevalence of mental health disorders, development of second-generation antipsychotics, growing geriatric population, improvements in healthcare infrastructure, and high investment in research and development.

The antipsychotic drugs market size is expected to see strong growth in the next few years. It will grow to $31.04 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the increasing incidence of schizophrenia and bipolar disorder, supportive government policies and funding, rising demand for personalized medicine, focus on reducing side effects, and growing mental health advocacy and support groups. Major trends in the forecast period include integration of digital health tools for monitoring, development of novel mechanisms of action, increasing focus on combination therapies, adoption of pharmacogenomics for tailored treatments, emphasis on patient-centric drug development.

The rising prevalence of mental disorders is anticipated to drive the growth of the antipsychotic drug market in the coming years. Mental disorders, also referred to as mental illnesses, affect an individual's thinking, behavior, mood, and overall mental health. Various factors such as stress, societal pressures, genetic predispositions, biochemical imbalances, neurodevelopmental issues, and physical health conditions can contribute to mental health problems. Antipsychotic drugs help manage these disorders by modifying the activity of neurotransmitters, mainly dopamine and serotonin, to alleviate psychotic symptoms, stabilize mood, and enhance cognitive and emotional functioning. For example, in November 2023, a survey by the Substance Abuse and Mental Health Services Administration (SAMHSA), a U.S.-based public health agency, revealed that about 6% of adults aged 18 and older, or 15.4 million people, reported experiencing serious mental illness (SMI). Additionally, in September 2024, the Australian Institute of Health and Welfare, an Australian government agency, projected that the number of people living with dementia in Australia will more than double, from approximately 411,100 in 2023 to 849,300 by 2058. This increase is expected to impact around 315,500 men and 533,800 women. As such, the growing incidence of mental disorders is fueling the expansion of the antipsychotic drug market.

Leading companies in the antipsychotic drug market are developing advanced medical products, such as subcutaneous atypical antipsychotic injections, to improve patient compliance and efficacy compared to traditional oral medications. These injections are administered under the skin and help in maintaining stable medication levels and better symptom control. For example, in April 2023, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, and MedinCell SA, a French manufacturer of biological products, introduced UZEDY, an FDA-approved extended-release injectable formulation of risperidone. This long-acting subcutaneous injection offers flexible dosing intervals of one or two months and employs MedinCell's proprietary SteadyTeq technology for consistent medication release, reaching therapeutic levels within 6-24 hours of administration. Clinical trials showed that UZEDY reduced the risk of schizophrenia relapse by up to 80% compared to a placebo, addressing adherence issues commonly associated with oral antipsychotics.

In March 2024, Bristol-Myers Squibb, a US-based pharmaceutical firm, acquired Karuna Therapeutics Inc. for $14 billion. This acquisition aims to significantly enhance Bristol-Myers Squibb's neuroscience portfolio by integrating Karuna's innovative antipsychotic treatment, KarXT. The deal also provides access to Karuna's early-stage and preclinical pipeline, potentially contributing to Bristol-Myers Squibb's long-term growth and diversification in neuroscience. Karuna Therapeutics Inc. is a US-based clinical-stage biopharmaceutical company focused on developing treatments for psychiatric and neurological conditions.

Major companies operating in the antipsychotic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., H. Lundbeck A/S, Dr. Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Alkermes plc

North America was the largest region in the antipsychotic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the antipsychotic drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antipsychotic drugs market consists of sales of long-acting injectables, depot injections, and atypical antipsychotics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antipsychotic Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antipsychotic drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antipsychotic drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antipsychotic drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Therapeutic Class: First Generation; Second Generation; Third Generation
2) By Disease: Schizophrenia; Bipolar Disorder; Unipolar Depression; Dementia; Other Diseases
3) By Distribution Channel: Hospital Pharmacies; Drug Stores; Online Pharmacies
Subsegments:
1) By First Generation: Typical Antipsychotics; Phenothiazines; Butyrophenones; Thioxanthenes; Dibenzoxazepines
2) By Second Generation: Atypical Antipsychotics; Clozapine; Olanzapine; Risperidone; Quetiapine; Aripiprazole; Paliperidone; Lurasidone
3) By Third Generation: Partial Dopamine Agonists; Aripiprazole; Brexpiprazole; Cariprazine
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck And Co. Inc.; AbbVie Inc.; Bristol-Myers Squibb Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29415

1. Executive Summary

2. Antipsychotic Drugs Market Characteristics

3. Antipsychotic Drugs Market Trends And Strategies

4. Antipsychotic Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Antipsychotic Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Antipsychotic Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Antipsychotic Drugs Market Growth Rate Analysis
5.4. Global Antipsychotic Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Antipsychotic Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Antipsychotic Drugs Total Addressable Market (TAM)

6. Antipsychotic Drugs Market Segmentation

6.1. Global Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First Generation
Second Generation
Third Generation
6.2. Global Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Other Diseases
6.3. Global Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Drug Stores
Online Pharmacies
6.4. Global Antipsychotic Drugs Market, Sub-Segmentation Of First Generation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Typical Antipsychotics
Phenothiazines
Butyrophenones
Thioxanthenes
Dibenzoxazepines
6.5. Global Antipsychotic Drugs Market, Sub-Segmentation Of Second Generation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Atypical Antipsychotics
Clozapine
Olanzapine
Risperidone
Quetiapine
Aripiprazole
Paliperidone
Lurasidone
6.6. Global Antipsychotic Drugs Market, Sub-Segmentation Of Third Generation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Partial Dopamine Agonists
Aripiprazole
Brexpiprazole
Cariprazine

7. Antipsychotic Drugs Market Regional And Country Analysis

7.1. Global Antipsychotic Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Antipsychotic Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antipsychotic Drugs Market

8.1. Asia-Pacific Antipsychotic Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antipsychotic Drugs Market

9.1. China Antipsychotic Drugs Market Overview
9.2. China Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antipsychotic Drugs Market

10.1. India Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antipsychotic Drugs Market

11.1. Japan Antipsychotic Drugs Market Overview
11.2. Japan Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antipsychotic Drugs Market

12.1. Australia Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antipsychotic Drugs Market

13.1. Indonesia Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antipsychotic Drugs Market

14.1. South Korea Antipsychotic Drugs Market Overview
14.2. South Korea Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antipsychotic Drugs Market

15.1. Western Europe Antipsychotic Drugs Market Overview
15.2. Western Europe Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antipsychotic Drugs Market

16.1. UK Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antipsychotic Drugs Market

17.1. Germany Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antipsychotic Drugs Market

18.1. France Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antipsychotic Drugs Market

19.1. Italy Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antipsychotic Drugs Market

20.1. Spain Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antipsychotic Drugs Market

21.1. Eastern Europe Antipsychotic Drugs Market Overview
21.2. Eastern Europe Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antipsychotic Drugs Market

22.1. Russia Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antipsychotic Drugs Market

23.1. North America Antipsychotic Drugs Market Overview
23.2. North America Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antipsychotic Drugs Market

24.1. USA Antipsychotic Drugs Market Overview
24.2. USA Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antipsychotic Drugs Market

25.1. Canada Antipsychotic Drugs Market Overview
25.2. Canada Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antipsychotic Drugs Market

26.1. South America Antipsychotic Drugs Market Overview
26.2. South America Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antipsychotic Drugs Market

27.1. Brazil Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antipsychotic Drugs Market

28.1. Middle East Antipsychotic Drugs Market Overview
28.2. Middle East Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antipsychotic Drugs Market

29.1. Africa Antipsychotic Drugs Market Overview
29.2. Africa Antipsychotic Drugs Market, Segmentation By Therapeutic Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Antipsychotic Drugs Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Antipsychotic Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antipsychotic Drugs Market Competitive Landscape And Company Profiles

30.1. Antipsychotic Drugs Market Competitive Landscape
30.2. Antipsychotic Drugs Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck And Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Antipsychotic Drugs Market Other Major And Innovative Companies

31.1. AstraZeneca PLC
31.2. GlaxoSmithKline PLC
31.3. Takeda Pharmaceutical Company Limited
31.4. Eli Lilly And Company
31.5. Teva Pharmaceutical Industries Ltd.
31.6. Sun Pharmaceutical Industries Ltd.
31.7. Otsuka Pharmaceutical Co. Ltd.
31.8. Aurobindo Pharma Ltd.
31.9. Cipla Ltd.
31.10. H. Lundbeck A/S
31.11. Dr. Reddy's Laboratories Ltd.
31.12. Intas Pharmaceuticals Ltd.
31.13. Apotex Inc.
31.14. Lupin Limited
31.15. Glenmark Pharmaceuticals Ltd.

32. Global Antipsychotic Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antipsychotic Drugs Market

34. Recent Developments In The Antipsychotic Drugs Market

35. Antipsychotic Drugs Market High Potential Countries, Segments and Strategies

35.1 Antipsychotic Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Antipsychotic Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Antipsychotic Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer